secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sonoma Pharmaceuticals, Inc. (SNOA)
CIK:        0001367083
Form:       8-K
Filed at:   2022-01-20T23:59:59+00:00
Accession:  0001683168-22-000342
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sonoma Pharmaceuticals enters two distribution deals for Microcyn products
--------------------------------------------------------------------------

- Non-exclusive distribution with Salus Medical for Microcyn dental/derm/wound/eye care in US; one-year initial term.
- Exclusive license to Anlicare for dental/oral products in China and Macau; five-year term after regulatory approval.
- Anlicare pays milestones-based royalties; must obtain regulatory licenses within two years or deal terminates.
- Salus can sell via own website only; no third-party platforms like Amazon.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1367083/000168316822000342/0001683168-22-000342-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1367083/000168316822000342/snoa_i8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-22-000342

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer